NHAS
Novo Holdings A/S Portfolio holdings
AUM $1.42B
1-Year Return
12.08%
This Quarter Return
-9.24%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.31B
AUM Growth
-$337M
(-20%)
Cap. Flow
-$148M
Cap. Flow
% of AUM
-11.26%
Top 10 Holdings %
Top 10 Hldgs %
74.12%
Holding
34
New
–
Increased
13
Reduced
4
Closed
3
Top Buys
| 1 |
CBLL
CeriBell, Inc. Common Stock
CBLL
|
+$10.6M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$10.6M |
| 3 |
Edgewise Therapeutics
EWTX
|
+$7.7M |
| 4 |
ArriVent BioPharma
AVBP
|
+$6.5M |
| 5 |
Vaxcyte
PCVX
|
+$6.23M |
Top Sells
| 1 |
TEM
Tempus AI, Inc. Class A Common Stock
TEM
|
+$138M |
| 2 |
Brookfield
BN
|
+$24.5M |
| 3 |
CRGX
CARGO Therapeutics
CRGX
|
+$24M |
| 4 |
Alibaba
BABA
|
+$10.6M |
| 5 |
Mersana Therapeutics
MRSN
|
+$6.08M |
Sector Composition
| 1 | Healthcare | 50.89% |
| 2 | Technology | 14.07% |
| 3 | Financials | 9.29% |
| 4 | Consumer Discretionary | 3.75% |
| 5 | Industrials | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
LanzaTech
LNZA
$44.5M
| $3.83M | 0.29% |
158,148
| – | – |
|
27
IO Biotech
IOBT
$113M
| $3.66M | 0.28% |
3,354,449
| – | – |
|
28
Kyverna Therapeutics
KYTX
$167M
| $3.57M | 0.27% |
1,850,000
| – | – |
|
29
AbCellera Biologics
ABCL
$1.43B
| $2.51M | 0.19% |
1,126,915
| – | – |
|
30
Marqeta
MQ
$2.6B
| $1.82M | 0.14% |
441,558
| – | – |
|
31
Galecto
GLTO
$3.64M
| $310K | 0.02% |
99,913
| – | – |
|
|
CRGX
32
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-1,663,724
| Closed | -$24M |
|
|
33
Mersana Therapeutics
MRSN
$36M
| – | – |
-170,000
| Closed | -$6.08M |
|
|
TEM
34
Tempus AI, Inc. Class A Common Stock
TEM
$15.1B
| – | – |
-4,074,419
| Closed | -$138M |
|